Access to therapies
Access to therapies content
There are many benefits to patient involvement in medicines approval and reimbursement processes.
The European Medicines Agency (EMA) is responsible for the approval and regulation of medicines in the EU.
Once a medicine has been approved at a European level, a separate applications for reimbursement is made at national level.
Idebenone (Raxone) A drug for the treatment of Leber hereditary neuropathy (LHON) was approved for reimbursement in Ireland in May 2019. The drug, which is called Idebenone…